ZYNE - Zynerba Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $8.63. This is a potential upside of $7.33 (563.85%) from yesterday's end of day stock price of $1.3.

Zynerba Pharmaceuticals's activity chart (see below) currently has 58 price targets and 54 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.94% with an average time for these price targets to be met of 87.58 days.

Most recent stock forecast was given by SUMANT KULKARNI from CANACCORD on 16-Aug-2023. First documented stock forecast 31-Aug-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Apr-2019

$1.11

$-0.19 (-14.62%)

2 years 7 months 23 days ago
(16-Aug-2023)

0/6 (0%)

$-0.18 (-13.95%)

Buy Since 07-Oct-2016

$23

2 years 7 months 24 days ago
(15-Aug-2023)

0/2 (0%)

$11.13 (93.77%)

Buy Since 14-Nov-2017

$8

4 years 8 months 6 days ago
(02-Aug-2021)

2/9 (22.22%)

$3.99 (99.50%)

113

Buy Since 31-Dec-2019

$7.25

$5.95 (457.69%)

$8.5

5 years 29 days ago
(10-Mar-2021)

1/4 (25%)

$2.91 (67.05%)

225

Buy Since 05-Jul-2018

$9

$7.7 (592.31%)

5 years 3 months 18 days ago
(21-Dec-2020)

0/4 (0%)

$5.56 (161.63%)

Show more analysts

Please expand the browser size to see the chart

What is ZYNE (Zynerba Pharmaceuticals) average time for price targets to be met?

On average it took 87.58 days on average for the stock forecasts to be realized with a an average price target met ratio 13.94

Which analyst has the current highest performing score on ZYNE (Zynerba Pharmaceuticals) with a proven track record?

MICHAEL HIGGINS

Which analyst has the most public recommendations on ZYNE (Zynerba Pharmaceuticals)?

Michael Higgins has 5 price targets and 3 ratings on ZYNE

Which analyst is the currently most bullish on ZYNE (Zynerba Pharmaceuticals)?

Lauren Chung with highest potential upside - $30.7

Which analyst is the currently most reserved on ZYNE (Zynerba Pharmaceuticals)?

Sumant Kulkarni with lowest potential downside - -$0.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?